ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma - Mensali, Nadia (Department of Cellular Therapy. Oslo University Hospital) ; Köksal, Hakan (Oslo University Hospital) ; Joaquina, Sandy (Oslo University Hospital) ; Wernhoff, Patrick (Oslo University Hospital) ; Casey, Nicholas P. (Oslo University Hospital) ; Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Panisello, Carla (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rodríguez, René (Instituto de Salud Carlos III) ; Vimeux, Lene (Université de Paris) ; Juzeniene, Asta (Oslo University Hospital) ; Myhre, Marit R. (Oslo University Hospital) ; Fåne, Anne (Oslo University Hospital) ; Castilla-Ramirez, Carolina (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Maggadottir, Solrun Melkork (Oslo University Hospital) ; Duru, Adil Doganay (Nova Southeastern University) ; Georgoudaki, Anna-Maria (Department of Oncology-Pathology. Karolinska Institutet) ; Grad, Iwona (Oslo University Hospital) ; Maturana, Andrés Daniel (Nagoya University) ; Gaudernack, Gustav (Department of Cancer Immunology. Oslo University Hospital) ; Kvalheim, Gunnar (Department of Cellular Therapy. Oslo University Hospital) ; Carcaboso, Angel M. (Institut de Recerca Sant Joan de Déu) ; De Álava, Enrique (Universidad de Sevilla) ; Donnadieu, Emma (Université de Paris) ; Bruland, Øyvind S (University of Oslo) ; Menendez, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Inderberg, Else Marit (Oslo University Hospital) ; Wälchli, Sébastien (Oslo University Hospital)